Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3

Rachel Hood Edwards1, Aron R Marquitz1, Nancy Raab-Traub2

  • 1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Mbio
|April 16, 2015
PubMed

Insights

Epstein-Barr virus protein LMP1

Area of Science:

  • Molecular virology and cell signaling.
  • Epigenetics and gene regulation.
  • Cancer biology and viral oncogenesis.

Background:

  • Epstein-Barr virus (EBV) protein latent membrane protein 1 (LMP1) influences host cell processes.
  • LMP1 possesses two NF-κB activating domains: CTAR1 and CTAR2, with distinct functions.
  • CTAR1 is crucial for B-lymphocyte transformation and activates PI3 kinase and EGFR.

Purpose of the Study:

  • To investigate the impact of LMP1-CTAR1 on cellular gene expression.
  • To identify the binding targets of the transcription factor bcl3 in LMP1-CTAR1-expressing cells.
  • To elucidate the role of bcl3 in mediating CTAR1-induced cellular changes.

Main Methods:

  • High-throughput sequencing (RNA-Seq) to analyze global gene expression changes.
  • Chromatin immunoprecipitation followed by sequencing (ChIP-Seq) to map bcl3 binding sites.
  • Ingenuity pathway analysis to interpret functional gene networks.

Main Results:

  • LMP1-CTAR1 induced limited transcriptional changes, with a notable decrease in expression for many genes.
  • ChIP-Seq identified over 2,000 bcl3 binding sites, primarily in gene promoter regions.
  • NFKB2 and PI3 kinase were among the genes bound by bcl3, and pathway analysis suggested modulation of NF-κB signaling.

Conclusions:

  • LMP1-CTAR1 uniquely affects cellular gene expression, partly via noncanonical NF-κB pathway activation.
  • Bcl3 is a key transcription factor involved in mediating CTAR1's effects on cellular expression.
  • The combined action of LMP1's CTAR1 and CTAR2 domains likely orchestrates complex cellular responses.
Abstract